41 related articles for article (PubMed ID: 11911866)
21. Delayed treatment with alpha-phenyl-N-tert-butyl nitrone (PBN) attenuates secondary mitochondrial dysfunction after transient focal cerebral ischemia in the rat.
Kuroda S; Katsura K; Hillered L; Bates TE; Siesjö BK
Neurobiol Dis; 1996 Apr; 3(2):149-57. PubMed ID: 9173922
[TBL] [Abstract][Full Text] [Related]
22. Nitrones as neuroprotective agents in cerebral ischemia, with particular reference to NXY-059.
Green AR; Ashwood T; Odergren T; Jackson DM
Pharmacol Ther; 2003 Dec; 100(3):195-214. PubMed ID: 14652110
[TBL] [Abstract][Full Text] [Related]
23. Development of the nitrone-based spin trap agent NXY-059 to treat acute ischemic stroke.
Lapchak PA; Araujo DM
CNS Drug Rev; 2003; 9(3):253-62. PubMed ID: 14530797
[TBL] [Abstract][Full Text] [Related]
24. Role of mitochondrial permeability transition in the immature brain following intrauterine ischemia.
Nakai A
J Nippon Med Sch; 2007 Jun; 74(3):190-201. PubMed ID: 17625367
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of secondary brain injury.
Siesjö BK; Siesjö P
Eur J Anaesthesiol; 1996 May; 13(3):247-68. PubMed ID: 8737117
[TBL] [Abstract][Full Text] [Related]
26. NXY-059: review of neuroprotective potential for acute stroke.
Fong JJ; Rhoney DH
Ann Pharmacother; 2006 Mar; 40(3):461-71. PubMed ID: 16507608
[TBL] [Abstract][Full Text] [Related]
27. NXY-059: a neuroprotective agent in acute stroke.
Wang CX; Shuaib A
Int J Clin Pract; 2004 Oct; 58(10):964-9. PubMed ID: 15587776
[TBL] [Abstract][Full Text] [Related]
28. Anti-cancer activity of nitrones and observations on mechanism of action.
Floyd RA; Chandru HK; He T; Towner R
Anticancer Agents Med Chem; 2011 May; 11(4):373-9. PubMed ID: 21651461
[TBL] [Abstract][Full Text] [Related]
29. Neuroimmunophilins: novel neuroprotective and neuroregenerative targets.
Guo X; Dillman JF; Dawson VL; Dawson TM
Ann Neurol; 2001 Jul; 50(1):6-16. PubMed ID: 11456311
[TBL] [Abstract][Full Text] [Related]
30. Protecting the brain: the search for a clinically effective neuroprotective drug for stroke.
Green AR
Crit Rev Neurobiol; 2004; 16(1-2):91-7. PubMed ID: 15581404
[TBL] [Abstract][Full Text] [Related]
31. Is NXY-059 an advancement in the treatment of acute ischaemic stroke?
Doggrell SA
Expert Opin Pharmacother; 2006 May; 7(7):965-8. PubMed ID: 16634718
[No Abstract] [Full Text] [Related]
32. Tamoxifen as a powerful neuroprotectant in experimental stroke and implications for human stroke therapy.
Kimelberg HK
Recent Pat CNS Drug Discov; 2008 Jun; 3(2):104-8. PubMed ID: 18537769
[TBL] [Abstract][Full Text] [Related]
33. Effect of NXY-059 on secondary mitochondrial dysfunction after transient focal ischemia; comparison with cyclosporin A.
Yoshimoto T; Kristián T; Hu B; Ouyang YB; Siesjö BK
Brain Res; 2002 Apr; 932(1-2):99-109. PubMed ID: 11911866
[TBL] [Abstract][Full Text] [Related]
34. The immunosuppressant drug FK506 ameliorates secondary mitochondrial dysfunction following transient focal cerebral ischemia in the rat.
Nakai A; Kuroda S; Kristián T; Siesjö BK
Neurobiol Dis; 1997; 4(3-4):288-300. PubMed ID: 9361306
[TBL] [Abstract][Full Text] [Related]
35. Nitrone-related therapeutics: potential of NXY-059 for the treatment of acute ischaemic stroke.
Maples KR; Green AR; Floyd RA
CNS Drugs; 2004; 18(15):1071-84. PubMed ID: 15581379
[TBL] [Abstract][Full Text] [Related]
36. Role and mechanisms of secondary mitochondrial failure.
Siesjö BK; Elmér E; Janelidze S; Keep M; Kristián T; Ouyang YB; Uchino H
Acta Neurochir Suppl; 1999; 73():7-13. PubMed ID: 10494335
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
